Immunopathologic Events at the Endplate in Myasthenia Gravis

Overview

Journal Springer Semin Immunopathol

Specialty Allergy & Immunology

Date 1985 Jan 1

PMID 2413561

Citations 6

Authors

T Ashizawa

S H Appel

Affiliations

Soon will be listed here.

Citing Articles

Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus.

Raymond W, Eilertsen G, Nossent J J Immunol Res. 2019; 2018:8051972.

PMID: 30687766 PMC: 6330819. DOI: 10.1155/2018/8051972.

The role of complement in experimental autoimmune myasthenia gravis.

Kusner L, Kaminski H Ann N Y Acad Sci. 2012; 1274:127-32.

PMID: 23252907 PMC: 3531867. DOI: 10.1111/j.1749-6632.2012.06783.x.

Complement and systemic lupus erythematosus.

Walport M Arthritis Res. 2002; 4 Suppl 3:S279-93.

PMID: 12110148 PMC: 3240161. DOI: 10.1186/ar586.

Immunopathogenesis and treatment of myasthenia gravis.

Levinson A, Zweiman B, Lisak R J Clin Immunol. 1987; 7(3):187-97.

PMID: 3036906 DOI: 10.1007/BF00915723.

Phenotypic characteristics of thymic B lymphocytes in myasthenia gravis.

Zweiman B, Levinson A, Lisak R J Clin Immunol. 1989; 9(3):242-7.

PMID: 2475519 DOI: 10.1007/BF00916820.

References

Weinberg C, Hall Z . Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors. Proc Natl Acad Sci U S A. 1979; 76(1):504-8. PMC: 382970. DOI: 10.1073/pnas.76.1.504. View

PLESCIA O, SEGOVIA J, Strampp A . An assessment of changes in the complement level of myasthenic sera. Ann N Y Acad Sci. 1966; 135(1):580-7. DOI: 10.1111/j.1749-6632.1966.tb45505.x. View

Engel A, Lindstrom J, LAMBERT E, Lennon V . Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology. 1977; 27(4):307-15. DOI: 10.1212/wnl.27.4.307. View

Almon R, Appel S . Serum acetylcholine-receptor antibodies in myasthenia gravis. Ann N Y Acad Sci. 1976; 274:235-43. DOI: 10.1111/j.1749-6632.1976.tb47689.x. View

Fambrough D . Control of acetylcholine receptors in skeletal muscle. Physiol Rev. 1979; 59(1):165-227. DOI: 10.1152/physrev.1979.59.1.165. View

Lindstrom J, Criado M, Hochschwender S, Fox J, Sarin V . Immunochemical tests of acetylcholine receptor subunit models. Nature. 1984; 311(5986):573-5. DOI: 10.1038/311573a0. View

Noda M, Takahashi H, Tanabe T, Toyosato M, Furutani Y, Hirose T . Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature. 1982; 299(5886):793-7. DOI: 10.1038/299793a0. View

Fulpius B, Miskin R, Reich E . Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors. Proc Natl Acad Sci U S A. 1980; 77(7):4326-30. PMC: 349827. DOI: 10.1073/pnas.77.7.4326. View

Bevan S, KULLBERG R, Heinemann S . Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture. Nature. 1977; 267(5608):263-5. DOI: 10.1038/267263a0. View

10.

Mochly-Rosen D, Fuchs S . Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site. Biochemistry. 1981; 20(20):5920-4. DOI: 10.1021/bi00523a041. View

11.

Russell D . Histological changes in the striped muscles in myasthenia gravis. J Pathol Bacteriol. 1953; 65(2):279-89. DOI: 10.1002/path.1700650202. View

12.

Albuquerque E, Lebeda F, Appel S, Almon R, Kauffman F, Mayer R . Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles. Ann N Y Acad Sci. 1976; 274:475-92. DOI: 10.1111/j.1749-6632.1976.tb47709.x. View

13.

Finer-Moore J, Stroud R . Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor. Proc Natl Acad Sci U S A. 1984; 81(1):155-9. PMC: 344629. DOI: 10.1073/pnas.81.1.155. View

14.

Lindstrom J . Experimental autoimmune myasthenia gravis. J Neurol Neurosurg Psychiatry. 1980; 43(7):568-76. PMC: 490624. DOI: 10.1136/jnnp.43.7.568. View

15.

Tzartos S, Lindstrom J . Monoclonal antibodies as probes of acetylcholine receptor structure. 2. Binding to native receptor. Biochemistry. 1981; 20(8):2181-91. DOI: 10.1021/bi00511a017. View

16.

Engel A, Fumagalli G . Mechanisms of acetylcholine receptor loss from the neuromuscular junction. Ciba Found Symp. 1982; (90):197-224. DOI: 10.1002/9780470720721.ch12. View

17.

Heinemann S, Merlie J, Lindstrom J . Modulation of acetylcholine receptor in rat diaphragm by anti-receptor sera. Nature. 1978; 274(5666):65-8. DOI: 10.1038/274065a0. View

18.

Kao I, Drachman D . Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science. 1977; 196(4289):527-9. DOI: 10.1126/science.850793. View

19.

Lefvert A, Bergstrom K . Immunoglobulins in myasthenia gravis: effect of human lymph IgG 3 and F (ab')2 fragments on a cholinergic receptor preparation from Torpedo marmorata. Eur J Clin Invest. 1977; 7(2):115-9. DOI: 10.1111/j.1365-2362.1977.tb01582.x. View

20.

Goldberg G, Mochly-Rosen D, Fuchs S, Lass Y . Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs. J Membr Biol. 1983; 76(2):123-8. DOI: 10.1007/BF02000612. View